INHSU 2017: People Who Use Drugs Should Be Prioritized for Hepatitis C Treatment
- Details
- Category: People Who Inject Drugs
- Published on Thursday, 21 September 2017 00:00
- Written by INHSU
People who use drugs should be given high priority for antiviral treatment as a way to eliminate hepatitis C as a public health concern, according to a statement issued at the 6th International Symposium on Hepatitis Care in Substance Users, held earlier this month in Jersey City.
HR17: Hepatitis C Virus Reinfection Is Uncommon After Being Cured with DAAs
- Details
- Category: HCV Treatment
- Published on Thursday, 18 May 2017 00:00
- Written by Liz Highleyman
Most people on opiate substitution therapy were successfully treated for hepatitis C with an interferon-free regimen of grazoprevir/elbasvir (Zepatier), and only a small number became reinfected during 3 years of follow-up, researchers reported at the 25th Harm Reduction International Conference this week in Montreal.
CROI 2017: Hepatitis C Treatment Can Be Provided Successfully at Syringe Exchange Sites
- Details
- Category: People Who Inject Drugs
- Published on Thursday, 13 April 2017 00:00
- Written by Liz Highleyman
Administering direct-acting antiviral therapy for people who inject drugs at a syringe exchange site led to high sustained response rates in a pilot study in New York City, researchers reported at the recent Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. Expanding treatment for this population could reduce hepatitis C virus (HCV) transmission and ultimately help eliminate hepatitis C as a public health threat.
More Articles...
- Coverage of 5th International Symposium on Hepatitis Care in Substance Users (INHSU 2016)
- INHSU 2016: Risk of Reinfection Is a Concern After Successful Hepatitis C Treatment
- INHSU 2016: HCV Treatment Effective and May Work as Prevention for People Who Inject Drugs
- INHSU 2016: Scaling Up Treatment in Prisons Could Help Halt Hepatitis C Epidemics
- INHSU 2016 Opens with Focus on Hepatitis C Prevention and Treatment for People Who Inject Drugs
- Interferon-Free Hepatitis C Treatment Safe and Effective for People Who Inject Drugs
- Grazoprevir/Elbasvir Hepatitis C Treatment Works Wells for People Who Inject Drugs
- EASL 2016: HCV Therapy Improves Quality of Life for People Who Inject Drugs, Reinfection Risk Remains
- AASLD 2015: Sofosbuvir + Ravidasvir Shows High Response Rates for Genotype 4 Hepatitis C
- AASLD 2015: Grazoprevir/ Elbasvir Shows High Cure Rate for People Who Inject Drugs
- Coverage of 4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015)
- INHSU 2015: HCV Treatment Works Well for People Who Inject Drugs, but Barriers to Access Remain
- INHSU 2015 Highlights Hepatitis C Prevention and Treatment for People Who Inject Drugs
- People Who Inject Drugs Should Have Access to Hepatitis C Treatment, Expert Panel Recommends
- People on Opiate Substitution Therapy Respond Well to AbbVie Hepatitis C Treatment
- Heroin Use Increasing in U.S. Population, Linked to Overdose Deaths, CDC Says
- AASLD 2014: Young Drug Injectors on Opioid Agonist Therapy Have Lower Risk of HCV Infection
- Opioid Maintenance Therapy Linked to Lower Hepatitis C Rates for People Who Inject Drugs
- Studies Reveal HIV and HCV Epidemics Among Injection Drug Users in the Middle East and North Africa
- CROI 2014: Monkey Studies Confirm Validity of Injectable PrEP
- CROI 2014: Long-acting GSK744 Protects Monkeys against HIV-like Virus [VIDEO]
- CROI 2014: HIV in People Who Use Drugs [VIDEO]
- EACS 2013: Tel Aviv Sees New HIV Epidemic Among People Who Inject Drugs
- Hepatitis C Prevention and Management for People Who Inject Drugs
- IAS 2013: Experts Discuss Role of Drug Policy in HIV, Hepatitis, and TB Epidemics
- Antiretroviral PrEP Prevents HIV Transmission among Injection Drug Users
- War on Drugs Is Major Driver of Global Hepatitis C Epidemic
- Direct-acting Antivirals Could Dramatically Reduce Hepatitis C Transmission among IDUs
- Naloxone Is Cost-effective Way to Prevent Heroin Overdose Deaths
- ICAAC 2012: Hepatitis C Can Be Successfully Treated in Injection Drugs Users with or without HIV
- High Rate of HCV Infection Shows Young Drug Injectors Need Better Prevention Interventions
- EACS 2011: People on Methadone Maintenance Can Be Successfully Treated for Hepatitis C
- Injection Drug Users and Adherence to Hepatitis C Treatment
- 10 Million Injection Drug Users May Have Hepatitis B or C
- Advocates Urge Consideration of Hepatitis C Treatment for Active Injection Drug Users
- House Democrats Propose Repeal of Funding Ban on Needle Exchange Programs
- Active Injection Drug Users and Those on Opiate Substitution Treatment Can Have Good Hepatitis C Therapy Outcomes
- Active Injection Drug Use Does Not Impair Sustained Response to Hepatitis C Treatment in Adherent Patients
- Adherence to Hepatitis C Treatment among Recovering Heroin Users on Methadone Maintenance